Studying cancer toxin in traditional Chinese medicine
Part of Cancer clinical trials.
This study is looking at the role of 'cancer toxin' in traditional Chinese medicine by collecting samples from healthy people and cancer patients. If you have a malignant tumor and have not had modern treatment (advanced stage) or finished chemo/radiation at least a month ago (early-mid stage), you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have been diagnosed with a malignant tumor (by biopsy or cell test).
- If your cancer is advanced, you haven't had any modern treatment yet. If your cancer is early or mid-stage, you finished chemo/radiation at least 1 month ago.
- You must sign a consent form agreeing to take part.
- You cannot have taken any antibiotics or probiotics in the past month.
- You cannot have other immune or infectious diseases, severe organ damage, or be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at fatigue in Chinese cancer patients to understand how common it is and how it affects their health. You may join if you have a confirmed cancer diagnosis and are at least 18 years old.
This study collects information about how cancer care affects daily life, treatment side effects, and quality of life, and it stores imaging and related data for future research. You might be able to take part if you’re scheduled for treatment at the center (or you’re a healthy volunteer) and can complete the questionnaires.
This study looks at young people (40 or younger at diagnosis) with solid tumors in China. It aims to collect real-world information about their treatments and outcomes to find patterns that could help improve care.
This trial studies how changing your immune system (with earlier treatments) affects cancer by collecting immune cells from your blood using a process called lymphapheresis. It may help researchers find better ways to monitor immune-related responses and side effects.
This trial looks at the microbes in your body (mostly from samples) to find clues—called biomarkers—that may help doctors understand or track cancer. You might be asked to share health information and provide samples before or around the time you start cancer treatment.
This study analyzes genetic information from cancer tumor samples to understand how genes affect treatment response and survival. By looking at leftover tissue or blood samples, researchers hope to better predict which treatments might work best for individual patients.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.